Seventy-five consecutive clinical Pseudomonas aeruginosa isolates were tested for in vitro exotoxin production. Exotoxin was demonstrated in culture filtrates biologically, by its ability to produce characteristic dermonecrotic lesions in guinea pigs, and serologically, by counterimmunoelectrophoresis (ClE) with rabbit antiserum elicited with purified exotoxin. By these two methods, exotoxin was detected in 87 and 89% ofP. aeruginosa strains, respectively (r = 0.48, P < 0.001). Although less sensitive than CIE in detecting exotoxin, immunodiffusion demonstrated a reaction of antigenic identity in most cases. Exotoxin was produced by all seven Fisher-Devlin immunotypes and by untypable strains. In contrast, exotoxin was not detected in the culture filtrates of 16 non-aeruginosa pseudomonas isolates and 48 non-pseudomonas organisms. The production of biologically similar and antigenically closely related exotoxins is thus a characteristic of the majority of P. aeruginosa strains derived from diverse clinical sources.
These data, suggesting the possible wide distribution of exotoxin among strains of P. aeruginosa, are confirmed in this study, which examines exotoxin production among a moderately large number of clinical pseudomonas isolates by biological and immunological tests. Exotoxin was detected in culture filtrates by its ability to produce characteristic dermonecrotic lesions in guinea pigs and by immunodiffusion and counterimmunoelectrophoresis (CIE) assays with specific rabbit antitoxin serum.
MATERIALS AND METHODS
Microorganisms. Seventy-five consecutive P. aeruginosa and other clinical isolates were obtained from the Bacteriology Laboratory, National Naval Medical Center, Bethesda, Md., between January and April 1976. Twelve additional strains representing various Pseudomonas species were obtained from the American Type Culture Collection, Rockville, Md. Standard identification procedures were used, including the API-20E system (Analytab Products, Inc., Plainview, N.Y.), for identification of the genera and species of the Enterobacteriaceae and tentative identification ofPseudomonas species (14) . Pseudomonas strains were characterized by growth in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) at 42°C, oxidation of maltose and mannitol, nitrite production, motility, ornithine and arginine decarboxylation, indolphenol oxidase reaction, fluorescence on Sellers medium, and liquefaction of gelatin (4).
Growth of organisms and preparation of culture filtrates. Stock cultures were streaked on Trypticase soy agar (TSA) plates (Baltimore Biological Laboratories, Cockeysville, Md.) and incubated overnight at 30°C. Isolated colonies were picked, streaked on TSA slants, and incubated overnight. The growth was suspended in Trypticase soy broth dialysate (TSBD) which contained 15% (vol/vol) glycerol and was stored in aliquots at -70°C.
For each experiment, an aliquot was thawed and used to inoculate a TSA slant. After overnight incubation at 30°C, growth from this slant was suspended in TSBD and used to inoculate 40 ml of TSBD in a 300-ml baffled nephelometer flask. To inhibit protease production (3), nitrilotriacetic acid (NTA) was added to this culture mixture in a final concentration of 5 mM. As shown in a previous study (3), this concentration of NTA has no effect on the growth of several Pseudomonas strains tested and enhances rather than depresses exotoxin production 776 Immunodiffusion. Culture filtrates prepared as above were concentrated 100-fold by means of a Minicon B15 concentrator (Amicon Corp., Lexington, Mass.). This procedure was performed at 4"C in order to limit proteolytic digestion of exotoxin. Slides measuring 50 by 75 mm were coated on one side with 6 ml of 1% refined agar (Oxoid Ionagar no. 2, Consolidated Laboratories, Inc., Chicago Heights, Ill.) in 0.75 M barbital buffer, pH 8.2. Antitoxin serum and concentrated culture filtrates were placed in appropriate agar wells, the slides were incubated for 24 h at room temperature and placed at 4VC overnight, and precipitin reactions were read the following day, without staining.
Guinea pig skin reactions. The backs of 600-g female guinea pigs were shaved and depilated with 5% calcium thioglycolate trihydrate cream (TildenYates Laboratories, Wayne, N.J.). A checkerboard pattern of 2-cm squares was drawn on each guinea pig's back, and 0. (Table 1) , was identical to that produced by injection of highly purified exotoxin. The intensity of this lesion correlated with the amount ofexotoxin present, as quantified by CIE (see below), and was totally abolished by heating filtrates at 560C for 30 min or by incubating them with antitoxin serum before injection.
Most culture filtrates contained varying amounts of both exotoxin and protease, even in the presence of 5 mM NTA, and produced char- No culture filtrates from 16 isolates tested, representing 9 non-aeruginosa Pseudomonas species, reacted with antitoxin serum or produced lesions in guinea pigs (Table 2) . Likewise, there were no positive CIE tests or guinea pig skin reactions among 47 non-pseudomonas isolates (Table 3) .
Culture filtrates from 53 clinical P. aeruginosa isolates were tested against antitoxin by immunodiffusion. Of these, 70% produced an identity reaction and 28% produced a line of non-identity in addition to (21%) or in lieu of (7%) an identity reaction (Table 4) . In most cases, reactions of identity were much stronger than those of non-identity, which were often barely visible (Fig. 1) . All 37 strains positive for exotoxin by immunodiffusion (i.e., producing a line of identity with purified exotoxin) were also positive by CIE, whereas 9 additional strains negative by immunodiffusion showed precipitin lines by CIE.
DISCUSSION
The lethality of pseudomonas exotoxin for experimental animals (1, 6; Pavlovskis et al., Microbiology-1975) , its similarity of action compared with diphtheria toxin (5), and its apparent release during human infections (13) make it a candidate for a pathogenic role. The data presented underscore the significance of this pathogenic potential by showing that immunologically and biologically closely related exotoxins are widely produced by clinical P. aeruginosa strains of diverse immunotypes.
The antigenic relatedness ofexotoxin derived from different strains of P. aeruginosa is suggested by the immunodiffusion tests and the close correlation between dermonecrosis produced in guinea pigs and intensity of precipitin reactions obtained by COE. These findings do not rule out other biologically similar but antigenically distinct pseudomonas exotoxins, which Liu and Hsieh suggest on the basis of unpublished data (7) . Possibly the three organisms we encountered that were negative for exotoxin by CIE but produced typical skin lesions represented the production of such a substance(s). It seems unlikely, however, on the basis of our data that if serologically heterologous exotoxins do exist they are as prevalent as exotoxin A.
Our ability to detect exotoxin in P. aeruginosa cultures was limited by the presence of varying amounts of protease, even when the protease inhibitor, NTA, was used, as well as by the sensitivity ofthe assays themselves. Our failure to demonstrate toxin by either immunoligical detection or skin reaction in a small percentage of the P. aeruginosa cultures tested may reflect these limitations rather than the actual inability of certain strains to produce toxin. In a related manner, both CIE and guinea pig skin reactivity were semiquantitative at best, especially in light ofthe presence of protease in most cultures. For these reasons, we did not attempt a quantitative comparison of exotoxin production by different strains, except to correlate CIE results with guinea pig skin reactions.
The ubiquity of immunologically closely related exotoxins with similar biological activity among many clinical strains of P. aeruginosa, coupled with the pathogenic potential as well as immunogenicity of exotoxin demonstrated in previous animal experiments, suggests the possibility of immunoprophylaxis or treatment of pseudomonas disease by active or passive immunization. The fact that many P. aeruginosa organisms contain exotoxin also underscores the possible diagnostic and epidemiological usefulness of measuring serum antitoxin that is present in high titer in patients recovering from recent pseudomonas infections and in low titer or not at all in uninfected subjects (13) .
